Arthur C. Butcher - Feb 21, 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP& Grp Pres, MedSurg & APAC
Signature: /s/ Susan Thompson, Attorney-in-Fact
Stock symbol: BSX
Transactions as of: Feb 21, 2023
Transactions value $: -$35,181
Form type: 4
Date filed: 2/22/2023, 03:54 PM
Previous filing: Feb 21, 2023
Next filing: Mar 24, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+1.71K	+5.97%	$0.00	30.4K	Feb 21, 2023	Direct	F1
transaction	BSX	Common Stock	Tax liability	-$35.2K	-761	-2.5%	$46.23	29.7K	Feb 21, 2023	Direct
holding	BSX	Common Stock						2.55K	Feb 21, 2023	By 401(k)	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-1.71K	-100%	$0.00^*	0	Feb 21, 2023	Common Stock	1.71K		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 21, 2020, the first anniversary of the date of grant.